Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Dr. Lal PathLabs's share price for the quarter that ended in Dec. 2024 was ₹2998.6. Dr. Lal PathLabs's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 83 Mil. Therefore, Dr. Lal PathLabs's market cap for the quarter that ended in Dec. 2024 was ₹249,933 Mil.
Dr. Lal PathLabs's quarterly market cap
increased
from Jun. 2024 (₹231,352 Mil) to Sep. 2024 (₹275,077 Mil) but then
declined
from Sep. 2024 (₹275,077 Mil) to Dec. 2024 (₹249,933 Mil).
Dr. Lal PathLabs's annual market cap
declined
from Mar. 2022 (₹215,777 Mil) to Mar. 2023 (₹151,608 Mil) but then
increased
from Mar. 2023 (₹151,608 Mil) to Mar. 2024 (₹188,282 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dr. Lal PathLabs's Enterprise Value for Today is ₹218,073 Mil.
Dr. Lal PathLabs Market Cap Historical Data
The historical data trend for Dr. Lal PathLabs's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr. Lal PathLabs's Market Cap
For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Lal PathLabs's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Market Cap distribution charts can be found below:
* The bar in red indicates where Dr. Lal PathLabs's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Dr. Lal PathLabs's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Lal PathLabs (BOM:539524) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Dr. Lal PathLabs Market Cap Related Terms
Thank you for viewing the detailed overview of Dr. Lal PathLabs's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:539524 has been successfully added to your 